BNB Plus Corp. (BNBX) announced that it has manufactured and shipped the largest single LineaDNA order in company history, valued at over $390,000. The approximately five-gram shipment, manufactured by the company’s LineaRx, Inc. subsidiary, was delivered under the company’s previously announced supply agreement for the bulk manufacture of LineaDNA used as a functional component of a cancer diagnostic test. The company anticipates fulfilling additional multi-gram deliveries under the supply agreement in the first half of the 2026 calendar year.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNBX:
- Applied DNA Sciences Approves Key Stockholder Proposals
- BNB Plus says LineaRx subsidiary expected to approach profitability in Q1 2026
- BNB Plus acquires 3,349 additional BNB tokens for approximately $3M
- Applied DNA Sciences Rebrands to BNB Plus Corp.
- Applied DNA chairperson Judy Murrah steps down, Josh Kruger to succeed